SCHEMBL4665474

SCHEMBL4665474

COc1ccc(C2(O)CCC(Cc3ccc(Cl)cc3)CC2CN(C)C)cc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 7/20 0.43
OPRM1 P35372 5/20 0.43
SLC6A4 P31645 5/20 0.43
SLC6A2 P23975 4/20 0.43
OPRD1 P41143 4/20 0.43
SLC22A1 O15245 2/20 0.43
CHRM2 P08172 1/20 0.43
CHRM1 P11229 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
ALDH1A1 P00352 1/20 0.41
AVPR1A P37288 1/20 0.40
EDNRA P25101 1/20 0.37
SLC6A3 Q01959 1/20 0.37
SLC6A9 P48067 1/20 0.36
SLC6A5 Q9Y345 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4665379 0.92 OPRK1 (0.42) OPRK1OPRM1SLC6A4SLC6A2OPRD1
SCHEMBL4663457 0.90 OPRM1 (0.43) OPRK1OPRM1SLC6A4SLC6A2OPRD1
SCHEMBL6944895 0.89 OPRK1 (0.37) OPRK1OPRM1SLC6A4SLC6A2OPRD1
SCHEMBL4665371 0.88 OPRK1 (0.39) OPRK1OPRM1SLC6A4SLC6A2OPRD1
SCHEMBL4663680 0.88 OPRK1 (0.60) OPRK1OPRM1SLC6A4SLC6A2OPRD1
SCHEMBL4663394 0.88 OPRK1 (0.53) OPRK1OPRM1SLC6A4SLC6A2OPRD1
SCHEMBL4665354 0.87 DRD2 (0.41) OPRK1OPRM1SLC6A4SLC6A2OPRD1
SCHEMBL4663483 0.87 DRD2 (0.41) OPRK1OPRM1SLC6A4SLC6A2OPRD1
SCHEMBL4664046 0.87 SMN1; SMN2 (0.48) OPRK1OPRM1SLC6A4SLC6A2OPRD1
SCHEMBL4663567 0.85 SMN1; SMN2 (0.43) OPRK1OPRM1SLC6A4SLC6A2OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1571140-B1 C-substituted cyclohexylmethylamine derivatives GRUENENTHAL GMBH (DE) 2008-11-12 EP claimed
US-7273952-B2 Substituted C-cyclohexylmethylamine derivatives GRUENENTHAL GMBH (DE) 2007-09-25 US claimed
US-20030232891-A1 Substituted C-cyclohexylmethylamine derivatives GRUENENTHAL GMBH (DE) 2003-12-18 US claimed
EP-1368299-A2 SUBSTITUTED C-CYCLOHEXYLMETHYLAMINE DERIVATIVES Grünenthal GmbH (DE) 2003-12-10 EP claimed
WO-2002030870-A2 SUBSTITUTED C-CYCLOHEXYLMETHYLAMINE DERIVATIVES Grünenthal GmbH (DE) 2002-04-18 WO claimed
EP-1571140-B1 C-substituted cyclohexylmethylamine derivatives GRUENENTHAL GMBH (DE) 2008-11-12 EP disclosed
US-7273952-B2 Substituted C-cyclohexylmethylamine derivatives GRUENENTHAL GMBH (DE) 2007-09-25 US disclosed
EP-1368299-B1 SUBSTITUTED C-CYCLOHEXYLMETHYLAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2006-07-26 EP disclosed
EP-1571140-A1 C-substituted cyclohexylmethylamine derivatives Grünenthal GmbH (DE) 2005-09-07 EP disclosed
US-20030232891-A1 Substituted C-cyclohexylmethylamine derivatives GRUENENTHAL GMBH (DE) 2003-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030232891-A1 Substituted C-cyclohexylmethylamine derivatives CNR2, CNR1, HNMT OPRK1 6/4885OPRM1 5/4885SLC6A4 358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.